Fuxin Digital (Hangzhou) Artificial Intelligence Co., Ltd. has recently declared the successful conclusion of its Pre-A funding round, amassing a total of RMB 50 million. Grace Capital took the helm as the lead investor in this funding endeavor, while Changling Capital, an existing investor, made an oversubscribed follow-up investment. The capital raised will be channeled primarily towards the technological enhancement, market outreach, channel diversification, and talent recruitment for FusionAi's range of medical artificial intelligence products.

At present, the scale of China's medical informatization market has soared to the hundred-billion-yuan mark. The advent of generative artificial intelligence has ushered in fresh avenues for growth within the sector. Fuxin Digital has introduced the innovative concept of "AI-driven full hospital processes" and has constructed a comprehensive medical intelligent service system. This system is designed to propel hospitals' transition from mere informatization to full-fledged intelligence.

Presently, the company's operations span the entire nation, catering to over 200 institutions. Founder Wu Di emphasized that AI serves as a collaborative ally for medical professionals and that the future of hospital informatization will gravitate towards an autonomous intelligent system. Both Grace Capital and Changling Capital harbor a positive outlook on Fuxin Digital's growth trajectory and are committed to offering unwavering support. Together, they aim to foster the innovation and practical application of AI in the healthcare domain.